New Zealand - English - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 114mg equivalent to atomoxetine 100 mg - capsule - 100 mg - active: atomoxetine hydrochloride 114mg equivalent to atomoxetine 100 mg excipient: gelatin   iron oxide red   iron oxide yellow   starch tekprint black sw-9008 tekprint black sw-9009 titanium dioxide   water   - indicated for the treatment of attention deficit/hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 20.5mg equivalent to atomoxetine 18 mg - capsule - 18 mg - active: atomoxetine hydrochloride 20.5mg equivalent to atomoxetine 18 mg excipient: gelatin   iron oxide yellow starch tekprint black sw-9008 tekprint black sw-9009 titanium dioxide   water   - indicated for the treatment of attention deficit/hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 28.5mg equivalent to atomoxetine 25 mg - capsule - 25 mg - active: atomoxetine hydrochloride 28.5mg equivalent to atomoxetine 25 mg excipient: gelatin   indigo carmine iron oxide yellow starch tekprint black sw-9008 tekprint black sw-9009 titanium dioxide   water   - indicated for the treatment of attention deficit/hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 45.5mg equivalent to atomoxetine 40 mg - capsule - 40 mg - active: atomoxetine hydrochloride 45.5mg equivalent to atomoxetine 40 mg excipient: gelatin   indigo carmine   iron oxide yellow   starch tekprint black sw-9008 tekprint black sw-9009 titanium dioxide   water   - indicated for the treatment of attention deficit/hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 68.3mg equivalent to atomoxetine 60 mg - capsule - 60 mg - active: atomoxetine hydrochloride 68.3mg equivalent to atomoxetine 60 mg excipient: gelatin   indigo carmine iron oxide yellow   starch tekprint black sw-9008 tekprint black sw-9009 titanium dioxide   water   - indicated for the treatment of attention deficit/hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 91.2mg equivalent to atomoxetine 80 mg - capsule - 80 mg - active: atomoxetine hydrochloride 91.2mg equivalent to atomoxetine 80 mg excipient: gelatin   iron oxide red iron oxide yellow starch tekprint black sw-9008 tekprint black sw-9009 titanium dioxide   water   - indicated for the treatment of attention deficit/hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

Canada - English - Health Canada

janssen inc - erdafitinib - tablet - 4mg - erdafitinib 4mg - antineoplastic agents

Canada - English - Health Canada

incyte corporation - pemigatinib - tablet - 4.5mg - pemigatinib 4.5mg - antineoplastic agents

Canada - English - Health Canada

incyte corporation - pemigatinib - tablet - 9mg - pemigatinib 9mg - antineoplastic agents

Canada - English - Health Canada

incyte corporation - pemigatinib - tablet - 13.5mg - pemigatinib 13.5mg - antineoplastic agents